Drug
Risedronic Acid clinical trials
Also written Risedronate.
- studies test it
- 70
- open now
- 2
- in phase 3
- 27
- first study started
- 1999
Keep track of what changes. Save the Risedronic Acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
69 studies that test it; most in 2004 (12)
| Year | Studies |
|---|---|
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 9 |
| 2003 | 9 |
| 2004 | 12 |
| 2005 | 3 |
| 2006 | 6 |
| 2007 | 7 |
| 2008 | 4 |
| 2009 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2023 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 11
- Phase 3
- 27
- Phase 4
- 25
- No phase
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 33 · Other 37
Warner Chilcott (15) · Sanofi (15) · Wake Forest University Health Sciences (3) · University of Nebraska (2) · Massachusetts General Hospital (2) · Alliance for Clinical Trials in Oncology (2) · Toronto Rehabilitation Institute (2) · Harbin Medical University (1)
Often tested with
Tested in the same studies.
Camrelizumab (1) · Vitamin D (1) · Testosterone (1) · Mecasermin (1) · Ibandronic Acid (1) · Alendronate (1) · Parathyroid Hormone (1) · Teriparatide (1)
Studies
Open first, then newest update. How each study uses Risedronic Acid is read from its arms, and is right about nine times in ten.
Testing it · 70
- Effects of Bisphosphonates on OI-Related Hearing LossRecruitingPhase 4Hospital for Special Surgery, New YorkNCT04152551Written as Risedronate Oral Tablet
- Bisphosphonate Use to Mitigate Bone Loss Secondary to Bariatric SurgeryRecruitingPhase 3Wake Forest University Health SciencesNCT04922333Written as Risedronate
- Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRTCompletedPhase 2Wake Forest University Health SciencesNCT03861091Written as risedronate
- Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and EfficacyActive, not recruitingPhase 2Harbin Medical UniversityNCT07471815Written as Camrelizumab + Risedronate Sodium + Chemotherapy
- Efficacy and Safety of Actonel® After Denosumab Discontinuation in Postmenopausal Osteoporosis WomenCompletedPhase 4Dong-A ST Co., Ltd.NCT05630768Written as Risedronate Sodium 35 MG [Actonel]
- Prevention of Osteoporosis in Breast Cancer SurvivorsCompletedNot applicableUniversity of NebraskaNCT00567606Written as Drug/Supplement only
- Heartland Osteoporosis Prevention StudyCompletedPhase 3University of NebraskaNCT02186600Written as Risedronate
- Effect of Actonel on Periodontal Health of Postmenopausal WomenWithdrawnPhase 4University Hospitals Cleveland Medical CenterNCT00594334Written as Risedronate
- Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal PatientsCompletedNot applicableHospital Regional 1o de OctubreNCT05346419Written as Risedronate
- Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of BoneCompletedPhase 2/3Institut National de la Santé Et de la Recherche Médicale, FranceNCT00445575Written as risedronate
- Effects of Bisphosphonates and Nutritional Supplementation After a Hip FractureCompletedNot applicableKarolinska InstitutetNCT01950169Written as Risedronate
- Weight Loss With Risedronate for Bone HealthCompletedPhase 4Wake Forest University Health SciencesNCT03411902Written as Risedronate Sodium 150 MG
- A Study of Actonel for the Prevention of Bone LossCompletedPhase 3M.D. Anderson Cancer CenterNCT00452439Written as Actonel (Risedronate)
- Bone Loss in Women With Anorexia NervosaCompletedPhase 2/3Massachusetts General HospitalNCT00089843Written as Actonel (risedronate)
- IGF-1 and Bone Loss in Women With Anorexia NervosaCompletedNot applicableMassachusetts General HospitalNCT01406444Written as Risedronate
- Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.CompletedPhase 1/2Montefiore Medical CenterNCT00266708Written as Risedronate
- Efficacy of Risedronate in Patients With Painful Periprosthetic Resorption of the Hip ProthesisTerminatedPhase 3University Hospital, LimogesNCT02744482Written as risedronate
- Do Bisphosphonates Alter the Skeletal Response to Mechanical Stimulation in Children With Osteogenesis Imperfecta?CompletedPhase 2Sheffield Children's NHS Foundation TrustNCT03208582Written as Risedronate Sodium
- Isoflavones for Promoting Calcium Absorption and Preventing Bone Loss in Post Menopausal WomenCompletedPhase 1Purdue UniversityNCT00244907Written as Genistein vs Risedronate
- Effect Of Risedronate On Bone Mass In Older Men Receiving Neoadjuvant Therapy For Prostate CancerCompletedPhase 4UConn HealthNCT00859027Written as risedronate
See all 70 studies that test Risedronic Acid →
As the comparator · 13 — what is tested is compared with Risedronic Acid
- Bone Turnover Markers and Treatment Efficacy in Postmenopausal OsteoporosisCompletedNot applicableKhyber Medical University PeshawarNCT07242612Written as Alendronate, Ibandronate; Risedronate
- A Study to Evaluate and Compare Alendronate and Risedronate on Bone Mineral Density in Women With Postmenopausal Osteoporosis (MK-0217-211)CompletedPhase 3Organon and CoNCT00092014Written as Risedronate 35 mg
- Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate TherapyCompletedPhase 3AmgenNCT00919711Written as Actonel®
- A Study That Will Compare the Effect of Two Drugs on Participants With Low Bone Mass and a Recent Hip FractureCompletedPhase 4Eli Lilly and CompanyNCT00887354Written as Risedronate
- VERtebral Fracture Treatment Comparisons in Osteoporotic WomenCompletedPhase 4Eli Lilly and CompanyNCT01709110Written as Risedronate
- Efficacy and Safety Study of Risedronate, Cholecalciferol Combination Tablet in Patients With OsteoporosisCompletedPhase 4Hanlim Pharm. Co., Ltd.NCT01675297Written as Risedronate
- A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.CompletedPhase 4Hoffmann-La RocheNCT00377234Written as Risedronate
- Post-menopausal Women Osteoporosis(Phase III)CompletedPhase 3Hanlim Pharm. Co., Ltd.NCT01806792Written as Risedronate
- Sequential Treatment of Postmenopausal Women With Primary Osteoporosis (FP-001-IM)CompletedPhase 3TakedaNCT00365456Written as Risedronate
- Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation PeriodCompletedPhase 3Novartis PharmaceuticalsNCT00103740Written as Risedronate
- Safety and Efficacy Trial With Zoledronic Acid for the Treatment of Paget's Disease of Bone, Including an Extended Observation PeriodCompletedPhase 3Novartis PharmaceuticalsNCT00051636Written as Risedronate
- Comparison of the Effects of 2 Drugs on Lumbar Spine Volumetric BMD in Men With Glucocorticoid-Induced OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00503399Written as Risedronate
- Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by OsteoporosisCompletedPhase 3Eli Lilly and CompanyNCT00343252Written as risedronate
Codes
What other systems call Risedronic Acid · ClinicalTrials.gg INT006506
- MeSH (NLM) D000068296Risedronic AcidConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) KM2Z91756ZRISEDRONIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 73056Confirmed FDA, Wikidata
- Wikidata Q408724risedronic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66517Risedronic AcidConfirmed FDA, Wikidata
- DrugBank DB00884One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000068296 | Risedronic Acid | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | KM2Z91756Z | RISEDRONIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 73056 | — | Confirmed FDA, Wikidata |
| Wikidata | Q408724 | risedronic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66517 | Risedronic Acid | Confirmed FDA, Wikidata |
| DrugBank | DB00884 | — | One source Wikidata |
Also registered as risedronate sodium (UNII OFG5EXG60L · RxNorm 60334).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.